Eichler C, Oesterwitz H, Kaden J, Schneider W, Schade R, Scholz D
Department of Urology, Humboldt-University of Berlin, G.D.R.
Immunol Lett. 1988 Dec;19(4):273-8. doi: 10.1016/0165-2478(88)90154-x.
The pretreatment of both kidney and heart donor with the photosensitizer 8-methoxy-psoralen followed by in vitro longwave ultraviolet graft irradiation (PUVA therapy) significantly prolonged graft survival times in rats even across a strong major histocompatibility complex (MHC) barrier. Immunohistological studies using monoclonal antibodies (Mab) to rat MHC class I and II antigens showed a significant reduction of class II antigen expression after PUVA therapy in both Sprague-Dawley rat kidneys and hearts. Using MHC class I Mab there were no differences in distribution pattern in untreated as well as in PUVA treated organs. Thus, our results represent the first in vivo evidence that photochemotherapy-induced graft survival time prolongation is closely connected with its ability to reduce MHC class II antigen expression.
用光敏剂8-甲氧基补骨脂素预处理肾脏和心脏供体,随后进行体外长波紫外线移植物照射(补骨脂素加紫外线A疗法),即使跨越强大的主要组织相容性复合体(MHC)屏障,也能显著延长大鼠移植物的存活时间。使用针对大鼠MHC I类和II类抗原的单克隆抗体(Mab)进行的免疫组织学研究表明,在补骨脂素加紫外线A疗法后,斯普拉格-道利大鼠的肾脏和心脏中II类抗原表达显著降低。使用MHC I类Mab,未处理器官和补骨脂素加紫外线A处理器官的分布模式没有差异。因此,我们的结果首次提供了体内证据,表明光化学疗法诱导的移植物存活时间延长与其降低MHC II类抗原表达的能力密切相关。